We are live on ! Find out more
CCEL icon

Cryo-Cell International

12 hedge funds and large institutions have $2.5M invested in Cryo-Cell International in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

2.19% less ownership

Funds ownership: 12.02%9.83% (-2.2%)

14% less funds holding

Funds holding: 1412 (-2)

42% less capital invested

Capital invested by funds: $4.33M → $2.5M (-$1.82M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
12
Holders Change
-2
Holders Change %
-14.29%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
4
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change

CCEL Hedge Fund Activity: Q1 2023 in Review

12 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q1 2023, worth a combined $2.5M — down 42% from $4.33M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CCEL and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Tower Research Capital (TRC), adding an estimated $5.97K. The largest seller was ISZO Capital Management, exiting entirely with an estimated $825K sold.

  • 12 institutional investors held Cryo-Cell International (CCEL) as of Q1 2023, down from 14 in Q4 2022.
  • Funds reported $2.5M of Cryo-Cell International stock for Q1 2023, down 42% quarter-over-quarter.
  • 0 funds opened new Cryo-Cell International positions in Q1 2023 and 2 closed out, a net change of -2 holders.
  • The largest Cryo-Cell International buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $5.97K added.
  • The largest Cryo-Cell International seller in Q1 2023 was ISZO Capital Management, an estimated $825K sold.

Based on aggregated 13F filings for Q1 2023.